View:
Download DOC
Download PDF
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Verduin Patricia
(Last) (First) (Middle)
COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NY 10022
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
05/06/2011 		3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 18,509 D
Common Stock 545 I By Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) 09/12/2008(1) 09/12/2013 Common Stock 17,000 68.15 D
Stock Option (Right to Buy) 09/11/2009(2) 09/11/2014 Common Stock 18,000 79.52 D
Stock Option (Right to Buy) 09/10/2010(2) 09/10/2015 Common Stock 20,000 73.23 D
Stock Option (Right to Buy) 09/16/2011(2) 09/16/2016 Common Stock 22,000 76.58 D
Explanation of Responses:
1. Option became exercisable in one-third increments on each anniversary date, with the first third becoming exercisable on the date shown in this column.
2. Option becomes exercisable in one-third increments on each anniversary date, with the first third becoming exercisable on the date shown in this column.
Remarks:
Nina Huffman by power of attorney 05/16/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

FORMS 3, 4 AND 5


	I, Patricia Verduin,an officer of
Colgate-Palmolive Company (the "Company"), do hereby appoint
Andrew D. Hendry, Katherine Hargrove Ramundo, Nina Huffman,
Joyce McCarthy, Kristine Hutchinson and J. Thomas Yust, and
each of them, as my true and lawful attorneys with the power
to execute and file on my behalf and in my place and stead, as
I myself could do if I were personally present, any Form 3, 4
or 5, any and all amendments thereto and any documents in
connection therewith, required to be filed by me with the
Securities and Exchange Commission pursuant to Section 16(a)
of the Securities Exchange Act of 1934, as amended, in
connection with my ownership, either directly or indirectly,
of securities of the Company, or any change therein.

	This Power of Attorney shall remain in full force
and effect for as long as I continue to be a director of the
Company or until earlier revoked by me in writing and
shall not otherwise be affected by my subsequent disability or
incompetence.

	In witness whereof, I have signed this instrument
 this  10th day of May, 2011.


			  /s/ Patricia Verduin

			Patricia Verduin